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Molluscum contagiosum virus (MCV) infects preadolescent children and sexually active adults, frequently causing a
disfiguring cutaneous disease in immunosuppressed HIV-infected individuals. The development of an efficacious treatment
regime has been hampered by the failure to replicate the virus in the laboratory. Here we report the first demonstration of
MCV replication in an experimental system. In human foreskin grafts to athymic mice, MCV induced morphological changes
which were indistinguishable from patient biopsies and included the development and migration of molluscum bodies
containing mature virions to the epidermal surface. q 1995 Academic Press, Inc.
Molluscum contagiosum virus (MCV) has the narrow- replication at 377 at various m.o.i. from 0.1 to 50 particles
per cell and between 2 and 9 days p.i. (data not shown).est host-range of vertebrate poxviruses (1, 2). It is a natu-
This result suggested that MCV had an extremely longral pathogen of humans and replicates only in the kera-
replication cycle, was terribly fastidious, or the particles,tinocyte of the epidermis. The infection is observed in
which were harvested from human lesions, had low in-children and adults, with spread within this latter group
fectivity and/or lost infectivity on storage.governed in part by sexual practices. Furthermore, MCV
Where examined, poxvirus virions have been shown tois a common opportunistic infection of immunosup-
be quite resistant to environmental insults (9– 11), and thepressed human immunodeficiency virus-infected pa-
epidemiology of MCV suggests that the MCV virion is alsotients (3 – 6). In the immunocompetent individual the dis-
stable on fomites (1, 2), although the virion-associatedease is long lasting, with the lesions persisting for
transcriptional machinery was less active than that frommonths or years, but ultimately regressing either sponta-
vaccinia virus virions (12). This suggested to us that it wasneously or in response to trauma, surgical or otherwise
unlikely that the virions we were using for infection of the(6, 7). Disease treatment has been hampered by failure
‘‘raft’’ cultures lacked infectivity. A more likely explanationto replicate the virus experimentally in tissue culture or
would be that MCV replication requires a condition(s) notanimal models, which prevents the identification of a
provided by ‘‘raft’’ cultures maintained in our hands or invirus process(es) suitable for the rational targeting of
other tissue culture systems (for additional references seeantiviral therapies.
13). This line of reasoning is reinforced by the recentWe first attempted to propagate MCV in a differentiated
observation that vaccinia virus intermediate gene tran-epidermis 5 –10 cells thick produced from human fore-
scription has a conditional requirement for a host factorskin keratinocytes grown on a dermal equivalent at a
(14). If MCV does require a distinct physiological state(s)liquid-air interface (‘‘raft culture’’; 8). Although we pro-
of the keratinocyte to initiate (and perhaps maintain) theduced and maintained for at least 6 weeks a multilayered
replication cycle, then it could take considerably longerepithelium that by histological criteria was indistinguish-
for MCV to replicate than the 12– 96 hr observed for mostable from authentic human foreskin, no evidence (dot
poxviruses. Histopathological observations and in situblot hybridization assay) could be obtained for MCV DNA
[3H]thymidine labeling of lesions suggests that MCV repli-
cates during the 9 to 15 days it takes the infected keratino-
cyte to reach the stratum granulosum, with virus specific1 To whom correspondence and reprint requests should be ad-
dressed at present address: Department of Molecular Microbiology changes detectable initially in the lower layers of the stra-
and Immunology, Saint Louis University School of Medicine, 1402 South tum spinosum, becoming progressively more prominent
Grand Blvd., St. Louis, MO 63104. Fax: (314) 773-3403.
with time and culminating with the formation of a mol-2 Present address: CB#7400 McGavran-Greenberg building, Depart-
luscum body (15–18). These studies, however, were un-ment of Epidemiology, School of Public Health, University of North
Carolina, Chapel Hill, N.C. 27599. able to determine the length of the eclipse period.
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We then chose to examine a second experimental sys- (mouse 23) days p.i. Figure 1A is a photograph of the
graft on mouse 7 on the day of sacrifice, 123 days p.i.,tem used by others to propagate another fastidious virus,
human papillomavirus (19, 20). Kreider and colleagues with the inset clearly showing the lesion projecting above
the epidermis. Light level microscopy of hematoxylin-had shown previously that athymic nude mice grafted
with skin from the rabbit, cow, or human would support eosin-stained paraffin-thick sections from formalin-fixed
tissues from mice 7, 10, and 23 revealed classic MCVreplication of Shope papillomavirus, bovine papillomavi-
rus, and human papillomavirus, respectively. Accord- histopathology (15– 18). As shown for mouse 7 in Figs.
1B, 1C, and 1D hypertrophied and hyperplastic epidermisingly, human foreskin tissue was infected with MCV and
grafted under the renal capsule of seven athymic mice extended down into the dermis without breaching the
basement membrane and projected up and above theusing conditions that resulted in 100% transformation
with human papillomavirus type 11 by 90 days p.i. Mice surface of the skin. By analogy to vaccinia virus, the
hyperplasia associated with the MCV lesions may becarrying the MCV-treated grafts were sacrificed at 105,
130, 153 and 174 days p.i. No evidence of MCV replica- mediated in part by an epidermal growth factor-like activ-
ity encoded by the virus (23, 24). The basal cells andtion was obtained in any of the grafts (R. M. L. Buller, J.
Burnett, and J. Kreider, unpublished results). To more their nuclei were enlarged. Beginning in the lower cells of
the stratum spinosum, intracytoplasmic inclusion bodiesclosely mimic the natural conditions of MCV replication,
MCV-treated human foreskins were grafted orthotopi- were detected (Fig. 1D, arrow). As the infected cells mi-
grate through the stratum granulosum, the inclusion bod-cally on the dorsolateral thorax of athymic mice. In the
first experiment, 12 foreskin grafts were infected with ies became larger, ultimately occupying a major portion
of the cell and relegating the nucleus to the periphery.MCV. Seven grafts failed to take and the remaining grafts
began rejection at approximately 50 days p.i. Interest- It is this cellular structure that is referred to as a mol-
luscum body and is pathogenomic for molluscum contag-ingly, 1 graft showed what appeared to be an early MCV
lesion of 5– 6 cells in the basal area of the epidermis. iosum. The remaining 5 mice were sacrificed at 142 days
p.i., and tissue was examined by light-level microscopy.This suggested that if the grafts could be maintained
longer we might be able to observe more vigorous virus One exhibited MCV pathology, while the remaining 4
specimens were negative. Thus out of a total of 8 longreplication. The extremely long eclipse period suggested
by this experiment was unanticipated as experimental term grafts, 4 or 50% showed evidence of MCV pathology.
Although the pathological changes observed by lightinfections of volunteers first by Juliusberg (21) and then
by Wiles and Kingery (22) found gross lesion develop- level histology of hematoxylin-eosin-stained sections
was diagnostic of MCV replication, we sought to confirmment 50 and 14 to 25 days p.i., respectively. In efforts to
reduce the rate of graft failure, healthy grafts were first this finding through in situ hybridization with biotinylated
MCV genomic DNA and rule out the involvement of otherestablished and then infected with MCV. Using these
conditions, 24 grafts were inoculated and 16 were re- poxviruses as unlikely as this might seem. As illustrated
in Fig. 1, the regions of the graft which showed histologicjected over the course of the experiments due to graft
failure. Of the remaining 8 grafts, 3 developed varied changes typical of MCV replication also reacted specifi-
cally with the MCV (Fig. 1E) but not to an EV (Fig. 1F)gross morphological changes that resembled authentic
MCV lesions by 74 (mouse 7), 108 (mouse 10), and 142 DNA probe. Electron microscopy further confirmed that
FIG. 1. Molluscum contagiosum virus-induced pathological changes in human foreskin grafts. Foreskins were surgically removed from healthy
newborn infants and stored at 47C in minimum essential medium. Within 24 hr of surgery, split-thickness grafts (approximately 1 cm2) were placed
orthotopically onto the dorsolateral panniculus carnosus of athymic nude mice and secured with Vaseline gauze, and an occlusive dressing of
gauze pads and adhesive tape. After 1 week the dressings were removed and after a further 3 weeks the healthy grafts were lightly scarified with
a 25-gauge needle and inoculated with 30 ml of a 1:6 dilution of a MCV stock solution which contained 2 1 108 MCV particles as estimated by
electron microscopy using a known concentration of latex spheres. The stock virus suspension was prepared within 24 hr of the surgical removal
of several MCV lesions (which were kept on ice) from a single patient. The virions were released from the lesion material by disruption in 0.5 ml
of 0.15 M NaCl using a hand-held, conical glass tissue grinder. The mice with infected grafts were housed in an isolator bubble until sacrifice for
microscopic examination of gross pathological changes or due to graft rejection. The major cause of graft rejection appeared to be the infiltration
of the graft by mouse leukocytes which correlated with graft dwindling and disappearance. (A) At 123 days p.i., mouse 7 was sacrificed and the
graft was photographed. The gross pathological changes of this graft were the most extensive of all of the grafts studied. (B) Tissue from the MCV-
treated foreskin graft on mouse 7 was fixed in Tellyesniczky’s acetic acid– ethanol–formalin solution, embedded in paraffin, sectioned at 4 mm, and
stained with hematoxylin –eosin before being examined with the light microscope. Arrowheads denote the junction between the dermis and
epidermis. Note the hyperplasia associated with the lesion which causes severe invagination of the epidermis but without loss of integrity of the
basal cell layer (arrows; line represents 100 mm). (C) A higher magnification of the area in B containing the upper arrow. Note the molluscum bodies
devoid of any cellular architecture exiting the surface of the epidermis (arrows; line represents 25 mm) (D) A higher magnification of the area in B
containing the lower arrow. The epidermis/dermis boundary is indicated by arrowheads. MCV-associated changes are noted in the cells just above
the basal layer (arrows; line represents 25 mm). (E/F) Graft tissue from mouse 10 was embedded, sectioned at 4 mm, deparaffinized, and hybridized
at room temperature for 2 hr with a biotinylated MCV (E) or ectromelia virus (F) DNA probe. DNA– DNA hybrids were detected with an avidin –
alkaline phosphatase developing system (arrows), and counterstained with nuclear Fast Red (line represents 25 mm).
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FIG. 2. The presence of MCV virions in a MCV-inoculated human foreskin graft. Graft tissue from mouse 10 was fixed for 3 hr in 2.5% glutaraldehyde
in Millonig’s sodium phosphate buffer (pH 7.9) and prepared for electron microscopy by standard protocols first using toluidine blue-stained 4-mm
sections to locate grossly the areas of MCV-induced pathology. Arrowheads denote pockets of mature virions (line represents 2 mm). The inset
shows the characteristic structure of the intracellular poxvirus virion (line represents 100 nm).
specimens showing MCV-like histopathology and reac- of antiviral treatments which are needed for chronic MCV
infections of AIDS patients. For example, we have pre-tivity with MCV-DNA probes, also contained the charac-
teristic mature, intracellular brick-shaped virions associ- viously shown that nitric oxide is a potent antiviral for
the replication of poxviruses vaccinia and ectromelia (31),ated with other poxvirus infections (Fig. 2; arrow). Of inter-
and we now plan to test the efficacy of nitric oxide donorest is the failure to observe large numbers of extracellular
compounds for anti-MCV activity using this animal model.poxvirus virions (25) either in these experimental infec-
tions or biopsy material (R. M. L. Buller, data not shown).
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To our knowledge this is the first demonstration of the
experimental propagation of MCV. It is not clear why
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